Skip to main content

Table 2 Observed multi-drug resistance among tuberculosis cases in Jiangsu Province, China

From: Epidemiology of anti-tuberculosis drug resistance in a chinese population: current situation and challenges ahead

Category Cases Drug resistant MDR
   HR HRE HRS HRSE  
   n(%) n(%) n(%) n(%) n(%)
Total 1824 37(2.03) 26(1.43) 94(5.15) 146(8.00) 303(16.61)
New cases 1180 9(0.76) 5(0.42) 33(2.80) 43(3.64) 90(7.63)
Previously treated cases 644 28(4.35) 21(3.26) 61(9.47) 103(15.99) 213(33.07)
χ 2   26.95 23.87 37.98 86.29 194.76
P   < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
  1. †: HR: isoniazid+rifampicin; HRE: isoniazid+rifampicin+ethambutol;
  2. HRS: isoniazid+rifampicin+streptomycin;
  3. HRSE: isoniazid+rifampicin+streptomycin+ethambutol
  4. ‡: MDR, resistant to at least isoniazid and rifampicin